News
Penn's Kiran Musunuru spoke with The Inquirer about the future of CRISPR technology.
20h
WISH-TV on MSNJuly Indiana Economic UpdateAs uncertain tariff news continues to dominate Wall Street, Indiana's economy may be impacted. Jane King, a Nasdaq Analyst, says that with the promised rollout of a new round of tariffs on August 1, ...
Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Modern weight loss medications represent a breakthrough, but they are most effective when combined with the right lifestyle strategies. Here's what that looks like.
Explore more
The Florida native was crowned the champion on the season 10 finale of RuPauls Drag Race All Stars, which dropped Friday, ...
Eli Lilly and Company (NYSE:LLY) is one of the high-margin pharma stocks to buy now. Eli Lilly and Company (NYSE:LLY) is set ...
UnitedHealth Group's pharmacy benefits manager, OptumRx Inc., was hit with an Employee Retirement Income Security Act of 1974 ...
“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...
GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.
A new study has found that an anti-obesity drug called tirzepatide, which is sold under the names Mounjaro for diabetes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results